Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Gentris of the US to Partner on Genomic Biomarkers with SIPM

publication date: Jun 22, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Gentris, a North Carolina pharmacogenomic services company, and the Shanghai Institutes of Preventive Medicine (SIPM) signed a memorandum of understanding that establishes a collaboration to discover genomic biomarkers. Gentris will identify US pharmas for personalized medicine projects, while SIPM will seek support from China organizations. The collaboration wants to build a network of academic, industry and public health collaborators to advance pharmacogenomics R&D. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...